Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Myeloid cell-based therapies in neurological disorders: How far have we come?

Böttcher C, Priller J.

Biochim Biophys Acta. 2016 Mar;1862(3):323-8. doi: 10.1016/j.bbadis.2015.10.003. Epub 2015 Oct 8.

Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease

Grimm A, Friedland K, Eckert A.

Biogerontology. 2016 Apr;17(2):281-96. doi: 10.1007/s10522-015-9618-4. Epub 2015 Oct 14.

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease

Sheng R, Tang L, Jiang L, Hong L, Shi Y, Zhou N, Hu Y.

ACS Chem Neurosci. 2016 Jan 20;7(1):69-81. doi: 10.1021/acschemneuro.5b00224. Epub 2015 Oct 28.

Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease

Song F, Qian Y, Peng X, Han G, Wang J, Bai Z, Crack PJ, Lei H.

Curr Opin Pharmacol. 2016 Feb;26:47-53. doi: 10.1016/j.coph.2015.09.015. Epub 2015 Oct 19.

A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease

Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, Lanctôt KL.

J Am Med Dir Assoc. 2016 Feb;17(2):142-7. doi: 10.1016/j.jamda.2015.08.019. Epub 2015 Oct 9.

The Role of Reelin Signaling in Alzheimer's Disease

Yu NN, Tan MS, Yu JT, Xie AM, Tan L.

Mol Neurobiol. 2016 Oct;53(8):5692-700. doi: 10.1007/s12035-015-9459-9. Epub 2015 Oct 21.

Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development

Kandimalla R, Vallamkondu J, Corgiat EB, Gill KD.

Brain Pathol. 2016 Mar;26(2):139-54. doi: 10.1111/bpa.12333. Epub 2015 Dec 8.

Common and Rare Genetic Variants Associated With Alzheimer's Disease

Marei HE, Althani A, Suhonen J, El Zowalaty ME, Albanna MA, Cenciarelli C, Wang T, Caceci T.

J Cell Physiol. 2016 Jul;231(7):1432-7. doi: 10.1002/jcp.25225. Epub 2015 Dec 17.

Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways

Duggan SP, McCarthy JV.

Cell Signal. 2016 Jan;28(1):1-11. doi: 10.1016/j.cellsig.2015.10.006. Epub 2015 Oct 21.

Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease

Simon MJ, Iliff JJ.

Biochim Biophys Acta. 2016 Mar;1862(3):442-51. doi: 10.1016/j.bbadis.2015.10.014. Epub 2015 Oct 22.

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

Minter MR, Taylor JM, Crack PJ.

J Neurochem. 2016 Feb;136(3):457-74. doi: 10.1111/jnc.13411. Epub 2015 Nov 18.

Interpretation of mushroom as a common therapeutic agent for Alzheimer's disease and cardiovascular diseases

Rahman MA, Abdullah N, Aminudin N.

Crit Rev Biotechnol. 2016 Dec;36(6):1131-1142. doi: 10.3109/07388551.2015.1100585. Epub 2015 Oct 30.

Astroglia dynamics in ageing and Alzheimer's disease

Verkhratsky A, Zorec R, Rodríguez JJ, Parpura V.

Curr Opin Pharmacol. 2016 Feb;26:74-9. doi: 10.1016/j.coph.2015.09.011. Epub 2015 Oct 26.

Linking T cells to Alzheimer's disease: from neurodegeneration to neurorepair

Bryson KJ, Lynch MA.

Curr Opin Pharmacol. 2016 Feb;26:67-73. doi: 10.1016/j.coph.2015.10.003. Epub 2015 Oct 27.

Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease

Villegas-Llerena C, Phillips A, Garcia-Reitboeck P, Hardy J, Pocock JM.

Curr Opin Neurobiol. 2016 Feb;36:74-81. doi: 10.1016/j.conb.2015.10.004. Epub 2015 Oct 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias